Vikas Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.50 M
as on 16-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 416.22%
(FY 2022)
- Profit 216.38%
(FY 2022)
- Ebitda 177.70%
(FY 2022)
- Net Worth 14.01%
(FY 2022)
- Total Assets 66.95%
(FY 2022)
About Vikas Biosciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sreenivasulu Kalle and Bhuvaneswari Durairaj serve as directors at the Company.
- CIN/LLPIN
U01400TG2016PTC103436
- Company No.
103436
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vikas Biosciences Private Limited offer?
Vikas Biosciences Private Limited offers a wide range of products and services, including Fresh Flowers, Plants & Trees, Plant Tissue Culture, Agricultural & Farm Consultants, Agricultural Testing Service, Fruit Plants.
Who are the key members and board of directors at Vikas Biosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreenivasulu Kalle  | Director | 22-Feb-2016 | Current |
| Bhuvaneswari Durairaj | Director | 22-Feb-2016 | Current |
Financial Performance of Vikas Biosciences.
Vikas Biosciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 416.22% increase. The company also saw a substantial improvement in profitability, with a 216.38% increase in profit. The company's net worth Soared by an impressive increase of 14.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vikas Biosciences?
In 2022, Vikas Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Green Fingers Agro Teck Private LimitedActive 2 years 6 monthsBhuvaneswari Durairaj is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vikas Biosciences?
Unlock and access historical data on people associated with Vikas Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vikas Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vikas Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
